<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01670617</url>
  </required_header>
  <id_info>
    <org_study_id>CSU2011-03B</org_study_id>
    <nct_id>NCT01670617</nct_id>
  </id_info>
  <brief_title>DeNovo NT Natural Tissue Graft Stratified Knee Study</brief_title>
  <official_title>A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Orthobiologics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Orthobiologics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long-term relief of pain and return to function
      for patients receiving DeNovo NT for cartilage lesions in the knee. DeNovo NT is a marketed
      product and has been used in more than 7,500 patients over the last 7 years.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in KOOS scores</measure>
    <time_frame>Between baseline and 24 months post surgery</time_frame>
    <description>Improvement in Knee Injury and Osteoarthritis Outcomes Survey (KOOS) scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>X-ray Evaluation</measure>
    <time_frame>Preop, 12 months and 24 months post surgery</time_frame>
    <description>X-ray evaluation of joint narrowing, and osteophyte and cyst formation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and time to reoperation/revision</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean IKDC Knee Examination grades</measure>
    <time_frame>Annually to 5 years post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI Evaluation</measure>
    <time_frame>Preop, 12 Months and 24 Months post surgery</time_frame>
    <description>Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>Annually to 5 years post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Defect of Articular Cartilage</condition>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>DeNovo NT Graft</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>DeNovo NT Graft stratified by lesion location - femur or patella</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Particulated Juvenile Articular Cartilage</intervention_name>
    <description>Treatment of articular cartilage defects up to 7.5 cm2</description>
    <arm_group_label>DeNovo NT Graft</arm_group_label>
    <other_name>DeNovo NT Natural Tissue Graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:

          1. Voluntary signature of the IRB approved Informed Consent,

          2. Male or female subjects between the ages of 18 to 55 years,

          3. If female: Actively practicing a contraception method and willing to continue for a
             minimum of 1 year postoperatively, practicing abstinence and willing to continue for a
             minimum of 1 year postoperatively, or sterile

          4. One or two contained lesion(s) of the femur or patella ≥ ICRS Grade 3 or OCD lesions
             with healed bone base with no loss of bone greater than 6mm

          5. Has peripheral cartilage debridement to healthy cartilage that results in at least one
             lesion with an area of ≥ 2 cm2 and ≤ 7.5 cm2,

          6. Lesion(s) to be treated must be contained/shouldered &gt; 70% of the periphery,

          7. Ligaments in the affected knee are stable,

          8. Ipsilateral knee compartment has intact menisci

          9. The contralateral knee is asymptomatic, stable, and fully functional,

         10. Is refractory to conservative non-surgical management or minimal surgical intervention
             and ≥ 3 months from the start of either treatment,

         11. Must record a response, at the preoperative study visit, of moderate to extreme pain
             for any one of the KOOS Pain Scale questions, P2 through P9.

         12. Must be physically and mentally willing and able, in the Investigator's opinion at the
             time of enrollment, to be compliant with the protocol

        EXCLUSION CRITERIA:

          1. Clinical disease diagnosis of the indexed affected joint that includes

               -  Osteoarthritis or avascular necrosis,

               -  Rheumatoid arthritis, or history of septic or reactive arthritis,

               -  Gout or a history of gout or pseudogout in the affected knee,

               -  Bipolar articular cartilage involvement (or kissing lesions)

               -  Has more than two clinically relevant chondral lesion(s) on the index knee,

               -  Osteochondritis dissecans of the knee with significant bone loss

               -  Associated damage to the underlying subchondral bone requiring bone graft,

               -  Has well-defined subchondral cyst(s),

               -  Has current or impending subchondral avascular necrosis,

          2. History of secondary arthropathies (i.e., sickle cell disease, hemochromatosis, or
             autoimmune disease),

          3. Uncontrolled diabetes,

          4. Displays a high surgical risk due to unstable cardiac and/or pulmonary disease,

          5. Has HIV or other immunodeficient state

          6. Is at substantial risk for the need of organ transplantation

          7. Is pregnant or breast-feeding,

          8. Body Mass Index &gt;35 (BMI=kg/m2),

          9. Is participating concurrently in another clinical trial

         10. Is receiving prescription pain medication other than NSAIDs or acetaminophen for
             conditions unrelated to the index knee condition, chronic use of anticoagulants, or
             taking corticosteroids,

         11. Has a neuromuscular, neurosensory, or musculoskeletal deficiency that limits the
             ability to perform objective functional assessment of either knee,

         12. Active joint infection or history of chronic joint infection at the surgical site,

         13. Prior total meniscectomy of either knee,

         14. Has severe patellofemoral malalignment/maltracking or patellar instability

         15. Radiographically has &gt;5 degrees of malalignment

         16. Has received, within the past 3 months HA or cortisone injections in knee,

         17. Has undergone prior tendon repair, meniscus repair, ligament repair or distal
             realignment/osteotomy surgery in the index knee, &lt; 6 months prior to surgery,

         18. Failed marrow stimulation or ACI treatment performed &lt; 12-mo before baseline,

         19. Index knee has been surgically treated for cartilage repair with OATs, mosaicplasty or
             osteochondral allograft,

         20. Involves concomitant procedures in the affected knee with the exception of incidental
             loose body removal, debridement, synovectomy, retinacular release, and/or partial
             meniscectomy

         21. Has contraindications for Magnetic Resonance Imaging (MRI),

         22. Has an allergy to Polymyxin B sulfate or Bacitracin antibiotics,

         23. Is receiving workman's compensation or currently involved in litigation relating to
             the index knee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kerlan Jobe Orthopaedics</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center San Deigo</name>
      <address>
        <city>San Deigo</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Orthopedic Consultants</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Andrews Institute for Orthopaedics &amp; Sports Medicine</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32561</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory Spine &amp; Sports Medicine Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TRIA Orthopaedic Center</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Orthopedic Sports Medicine Institute at Twin Cities Orthopedics</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.T. Still University of Health Sciences</name>
      <address>
        <city>Kirksville</city>
        <state>Missouri</state>
        <zip>63501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Orthopaedic Associates</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Orthopaedic Consultants</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Antonio Military Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's College Hospital</name>
      <address>
        <city>Toronoto</city>
        <zip>M5S 1B1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Farr J, Cole BJ, Sherman S, Karas V. Particulated articular cartilage: CAIS and DeNovo NT. J Knee Surg. 2012 Mar;25(1):23-9.</citation>
    <PMID>22624244</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2012</study_first_submitted>
  <study_first_submitted_qc>August 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2012</study_first_posted>
  <last_update_submitted>January 25, 2017</last_update_submitted>
  <last_update_submitted_qc>January 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

